StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of NYSE AMPE opened at $0.33 on Monday. Ampio Pharmaceuticals has a 1-year low of $0.14 and a 1-year high of $8.30. The business has a fifty day moving average price of $1.11 and a 200 day moving average price of $1.82. The stock has a market capitalization of $376,200.00, a P/E ratio of -0.03 and a beta of 1.95.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last released its quarterly earnings results on Wednesday, March 27th. The company reported ($2.48) EPS for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- What is the S&P/TSX Index?
- AMD is Down 35%. Now is the Time to Buy the Dip
- The How And Why of Investing in Oil Stocks
- Amazon Stands Tall: New Highs Are in Sight
- Investing in Commodities: What Are They? How to Invest in Them
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
